Finally sofosbuvir: an oral anti-HCV drug with wide performance capability

Overview of attention for article published in Pharmacogenomics and Personalized Medicine, December 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog

twitter: 1 X user
patent: 2 patents

Citations

dimensions_citation: 39 Dimensions

Readers on

mendeley: 78 Mendeley

Summary News Blogs X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Hepatitis C virus inhibitors

Grant US-9127021-B2

United States of America

HEPATITIS C VIRUS INHIBITORS

Application US-20110250172-A1

United States of America